{'fraction_non_alphanumeric': 0.027923211169284468, 'fraction_numerical': 0.012216404886561954, 'mean_word_length': 4.797979797979798, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
LaCARP seeks patients for trial of immune system builder.


 The Louisiana Community AIDS Research Program (LaCARP) at Tulane University is recruiting and enrolling volunteers for a trial on the effectiveness of recombinant Interleukin-2 (rIL-2), in helping to build the immune system. The study is open to patients with T-cell counts greater than 350. Volunteers will receive injections twice daily for 5 days, every 8 weeks. This will last for three cycles, and participants will continue taking their other medications during the trial. Contact information is included.
